Antibiotic resistance surveillance is particularly important in countries where access to new antibiotics is limited and where more knowledge is needed about resistance across humans, animals, food and the environment.
This was a central focus of SeqAfrica, led by the DTU National Food Institute. Through the project, whole-genome sequencing was used to strengthen surveillance of resistant bacteria and generate new knowledge about how antibiotic resistance develops and spreads across sectors.
Malawi provides a concrete example of how expertise and methods developed through SeqAfrica have been applied in national antibiotic resistance surveillance. Here, analyses based on whole-genome sequencing have provided new insights into ESBL-producing E. coli from both humans and animals.Genomic data can provide authorities and professionals with a stronger evidence base for understanding where resistant bacteria emerge, how they spread and where prevention or further investigation may be needed
New insights from Malawi
The findings from Malawi were presented at the African Society for Laboratory Medicine’s conference in Nairobi in November 2025. At the conference, Innocent Chibwe from the Public Health Institute of Malawi (PHIM) received an award for his work on whole-genome sequencing.
The award illustrates how professionals have developed expertise in whole-genome sequencing and bioinformatics through SeqAfrica and are applying it in national antibiotic resistance surveillance.
The work draws on a dataset of ESBL-producing E. coli collected from both humans and animals. ESBL-producing bacteria can break down several types of antibiotics, making infections caused by these bacteria difficult to treat.
By analysing the bacteria’s genetic material, researchers can identify the resistance genes they carry and determine how closely they are related.
The analyses revealed a high prevalence and wide variety of resistance genes in the isolates examined, as well as genetic overlap between human and animal isolates. The findings included genes associated with resistance to antibiotics considered last-resort treatment options in Malawi.
From technology to preparedness
SeqAfrica was carried out in collaboration with regional sequencing centres and national partners in Africa. The project included method development, training, bioinformatics analysis and quality assurance.
Expertise and methods developed through SeqAfrica were also used during the unusual cholera outbreak in Malawi in 2022–2023. The project’s genomic protocols were used to examine samples suspected of containing cholera bacteria. The work showed that some of the isolates were not Vibrio cholerae.
The experience from Malawi highlights the need to monitor antibiotic resistance across humans, animals, food and the environment. A One Health approach is therefore essential.
About SeqAfrica
SeqAfrica was a Fleming Fund-supported project led by the Research Group for Global Capacity Building at the DTU National Food Institute.
The project strengthened African countries’ capacity to use whole-genome sequencing and bioinformatics in antibiotic resistance surveillance across humans, animals, food and the environment.
Across its activities, SeqAfrica generated more than 36,000 genomes from 24 countries, including more than 25,000 bacterial genomes and more than 10,000 SARS-CoV-2 genomes. The work contributed to more than 60 scientific publications and included training for more than 200 researchers and laboratory staff.
SeqAfrica collaborated with regional sequencing centres and national partners in Africa, including the National Institute for Communicable Diseases in South Africa, the Noguchi Memorial Institute for Medical Research in Ghana and the Institut Pasteur de Dakar in Senegal.